Researchers at the UC Santa Barbara-Sanford|Burnham Center for Nanomedicine just may have unlocked an important door in the treatment of cancerous tumors. The center recently announced the discovery of an amino acid compound called iRGD. iRGD helps existing cancer-fighting chemotherapy drugs penetrate deep into malignant tumors, while leaving the surrounding healthy tissue untouched and patients potentially without side-effects.
Dr. Erkki Ruoslahti, distinguished professor and founding member of the UC Santa Barbara-Sanford|Burnham Center, was in the studio this morning. He explained in-depth the details and potential implications of this very exciting breakthrough in cancer treatment.